The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of prophylactic tocilizumab (toci) for the reduction of cytokine release syndrome (CRS) to inform the management of patients (pts) treated with teclistamab in MajesTEC-1.
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bayer (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Cellectis (Inst); Janssen (Inst); Novartis (Inst)
 
Alfred L. Garfall
Stock and Other Ownership Interests - Cabaletta Bio
Consulting or Advisory Role - Amgen; CDR-Life; GlaxoSmithKline; Janssen Oncology
Research Funding - crispr therapeutics (Inst); Janssen Oncology (Inst); Novartis (Inst); Tmunity Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Patent in the field of CAR T cell therapy
 
Lotfi Benboubker
Consulting or Advisory Role - Bretonneau Hospital, Regional University Hospital Center (Inst)
Travel, Accommodations, Expenses - Abbvie; Sanofi
Other Relationship - Bretonneau Hospital, Regional University Hospital Center (Inst)
 
Katarina Uttervall
No Relationships to Disclose
 
Kaz Groen
No Relationships to Disclose
 
Laura Rosiñol
Honoraria - Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Sanofi
 
Caroline Hodin
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology
 
Tara Stephenson
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology
 
Danielle Trancucci
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Alfredo Perales-Puchalt
Employment - Geneos; Janssen
Stock and Other Ownership Interests - AstraZeneca; Geneos; GlaxoSmithKline; Globus; IgM Biosciences; Johnson & Johnson/Janssen; Merck; Pfizer; Vanda Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Methods and compositions for treating cancer - WO2016054153A1 Optimized Synthetic Consensus Immunogenic Compositions Targeting the Follicle Stimulating Hormone Receptor (FSHR) - WO2018044929A1 (Inst)
 
Rachel Kobos
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen
 
Arnob Banerjee
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda